The Department of Defense has teamed up with Berg to discover biomarkers for prostate cancer with the goal of identifying more effective treatments for the disease. Berg will analyze prostate cancer data using its Interrogative Biology technology. The collaboration is part of a cooperative research and development agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine and the Center for Prostate Disease Research of the Uniformed Services University of the Health Sciences.

Related Summaries